INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
Real-World Data Has Real Impact On Clinical Research
The ultimate goal of using real-world data (RWD) in clinical research is to ensure a patient is on the right therapy and receiving the right care at the right point in their healthcare journey.
-
Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations
Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.
-
5 Projections For 2026: Navigating The New Normal In Clinical Trials
In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.
-
A New Era Of ADC Development Demands A New Kind Of Partner
Explore how to navigate the evolution of antibody-drug conjugates by mastering AI-driven selection, dose optimization, and new regulatory strategies for earlier-line clinical success.
-
Days Instead Of Weeks: What It Actually Takes To Close The DBL-To-TLF Gap6/25/2026
The weeks after database lock often stall reporting. Here's how automated, deterministic TLF generation speeds up that timeline.
-
Reimagine Quality: Responding To EOL Deadlines10/14/2026
Delay, migrate, or reimagine? Learn how rethinking quality operations around AI can triple team productivity and keep you inspection-ready for the next decade.
-
Don't Just Swap The Engine. Redesign The Factory.6/4/2026
Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.
-
Translating R3 Data Governance And Oversight Into Practice7/18/2026
Learn how to translate ICH E6(R3) into practice with actionable strategies for proactive risk management, robust data governance, and earlier deviation detection.
-
Remote Patient Monitoring Using Mobile Health Technology3/28/2025
This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
Trial Enablement Solutions
Digital health technologies have the potential to transform clinical trials, yet without careful planning and operational support, their implementation can create complexity, increase site burden, and jeopardize data quality.
Backed by over 20 years of experience across nearly 300 industry-sponsored trials, Ametris’ Digital Health Operations team delivers end-to-end trial enablement services to ensure seamless technology deployment, reduce site burden, and capture reliable, high-quality data.
-
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
-
Medidata Interim Lock enhances automation and efficiency in managing clinical study databases by streamlining the interim lock process.
-
The success of clinical trials depends on patient participation.
But patients and caregivers need reliable support first.
Being part of a trial is often nuanced and time-consuming. Archaic travel, antiquated payment processes and card fees are not only frustrating, but can also chip away at the reimbursement funds participants are owed.
This isn’t what you want for your participants, but you haven’t had a better choice. If we have the technology to make things better, we should. So we are.
Mural Link is the clinical research industry’s first participant management platform, designed to meet the needs of modern-day participants, help them enroll and remain in a trial, and reduce the administrative burden for sites.
-
Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.
They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.
Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.